Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilaria Cuomo

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Acta Bio-Medica : Atenei Parmensis|August 29, 2017
Clinical stabilisation with lacosamide of mood disorder comorbid with PTSD and fronto-temporal epilepsyIlaria Cuomo, Georgios D Kotzalidis, Sergio De Filippis
Psychiatry and Clinical Neurosciences|September 26, 2018
Lacosamide in bipolar disorder: A 30-day comparison to a retrospective control group treated with other antiepilepticsIlaria Cuomo, Daria Piacentino, Georgios D Kotzalidis, et al.
Journal of Gambling Studies|February 7, 2013
Citalopram-associated gambling: a case reportIlaria Cuomo, Georgios D Kotzalidis, Federica Caccia, et al.
General Hospital Psychiatry|April 24, 2012
Risperidone-induced leukopenia: a case report and brief review of literatureGiovanni Manfredi, Andrea Solfanelli, Giorgia Dimitri, et al.
Current Neuropharmacology|January 14, 2021
Vortioxetine vs. Other Antidepressants in Patients with Major Depressive Episode With or Without Substance Use DisorderGeorgios D Kotzalidis, Ginevra Lombardozzi, Marta Matrone, et al.
Neuropsychiatric Disease and Treatment|June 29, 2018
Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of lifeIlaria Cuomo, Georgios D Kotzalidis, Simone de Persis, et al.
Frontiers in Psychiatry|January 24, 2020
Aripiprazole Long-Acting Injection During First Episode Schizophrenia-An Exploratory AnalysisGloria Giordano, Lorenzo Tomassini, Ilaria Cuomo, et al.
Journal of Clinical Psychopharmacology|February 14, 2015
Hiccup with aripiprazole plus benzodiazepines resolving with pregabalin and/or benzodiazepine switch/discontinuation: four case reportsSergio De Filippis, Valentina Ranieri, Ilaria Cuomo, et al.
Therapeutic Advances in Psychopharmacology|March 4, 2017
Does the efficacy of asenapine in bipolar disorder increase in the presence of comorbidity with a substance use disorder? A naturalistic studySergio De Filippis, Ilaria Cuomo, Georgios D Kotzalidis, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|April 16, 2011
The impact of anxiety, depression, and suicidality on quality of life and functional status of patients with congestive heart failure and hypertension: an observational cross-sectional studyGianluca Serafini, Maurizio Pompili, Marco Innamorati, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Acta Bio-Medica : Atenei Parmensis|August 29, 2017
Clinical stabilisation with lacosamide of mood disorder comorbid with PTSD and fronto-temporal epilepsyIlaria Cuomo, Georgios D Kotzalidis, Sergio De Filippis
Psychiatry and Clinical Neurosciences|September 26, 2018
Lacosamide in bipolar disorder: A 30-day comparison to a retrospective control group treated with other antiepilepticsIlaria Cuomo, Daria Piacentino, Georgios D Kotzalidis, et al.
Journal of Gambling Studies|February 7, 2013
Citalopram-associated gambling: a case reportIlaria Cuomo, Georgios D Kotzalidis, Federica Caccia, et al.
General Hospital Psychiatry|April 24, 2012
Risperidone-induced leukopenia: a case report and brief review of literatureGiovanni Manfredi, Andrea Solfanelli, Giorgia Dimitri, et al.
Current Neuropharmacology|January 14, 2021
Vortioxetine vs. Other Antidepressants in Patients with Major Depressive Episode With or Without Substance Use DisorderGeorgios D Kotzalidis, Ginevra Lombardozzi, Marta Matrone, et al.
Neuropsychiatric Disease and Treatment|June 29, 2018
Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of lifeIlaria Cuomo, Georgios D Kotzalidis, Simone de Persis, et al.
Frontiers in Psychiatry|January 24, 2020
Aripiprazole Long-Acting Injection During First Episode Schizophrenia-An Exploratory AnalysisGloria Giordano, Lorenzo Tomassini, Ilaria Cuomo, et al.
Journal of Clinical Psychopharmacology|February 14, 2015
Hiccup with aripiprazole plus benzodiazepines resolving with pregabalin and/or benzodiazepine switch/discontinuation: four case reportsSergio De Filippis, Valentina Ranieri, Ilaria Cuomo, et al.
Therapeutic Advances in Psychopharmacology|March 4, 2017
Does the efficacy of asenapine in bipolar disorder increase in the presence of comorbidity with a substance use disorder? A naturalistic studySergio De Filippis, Ilaria Cuomo, Georgios D Kotzalidis, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|April 16, 2011
The impact of anxiety, depression, and suicidality on quality of life and functional status of patients with congestive heart failure and hypertension: an observational cross-sectional studyGianluca Serafini, Maurizio Pompili, Marco Innamorati, et al.
Pageof 3